MoonLake Immunotherapeutics (MLTX) Exchange Rate Effect (2021 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly Exchange Rate Effect came in at -$483000.0 in Q1 2026, down 448.86% year-on-year from $138449.5 in Q1 2025, and down 630.77% quarter-over-quarter from $91000.0 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$483000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 448.86% year-over-year to -$483000.0 in Q1 2026; TTM through Mar 2026 was $714000.0, a 12000.0% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 766.41% from the prior year.
- Exchange Rate Effect eased to -$483000.0 in Q1 2026 per MLTX's latest filing, from $91000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q2 2025 and bottomed at -$483000.0 in Q1 2026.
- The 5-year median for Exchange Rate Effect is -$6504.0 (2022), against an average of $40384.7.
- Biggest YoY gain for Exchange Rate Effect was 8698.13% in 2024; the steepest drop was 6592.21% in 2024.
- Year by year, Exchange Rate Effect stood at -$8286.0 in 2022, then surged by 872.95% to $64047.0 in 2023, then soared by 562.01% to $424000.0 in 2024, then plunged by 78.54% to $91000.0 in 2025, then sank by 630.77% to -$483000.0 in 2026.
- Per Business Quant, the three latest MLTX Exchange Rate Effect figures stand at -$483000.0 (Q1 2026), $91000.0 (Q4 2025), and -$285000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.35 Bn | 991.29 Mn | - | -483,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -483,000.00 |
| Mar 31, 2026 | -483,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | -285,000.00 |
| Sep 30, 2025 | -285,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | -88,000.00 |
| Mar 31, 2025 | -88,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Sep 30, 2024 | -325,000.00 |
| Sep 30, 2024 | -325,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2023 | 64,047.00 |
| Dec 31, 2023 | 64,047.00 |